Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Patient's own blood components outperform daily ED pills?

NCT ID NCT07761806

Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether injecting platelet-rich plasma (PRP) into the penis, taking a daily oral erectile dysfunction medication (tadalafil 5 mg), or using both together can better improve erectile function in men with organic erectile dysfunction. About 75 men who have had the condition for at least six months will be randomly assigned to one of the three approaches. The study measures improvement using a standard questionnaire called the International Index of Erectile Function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP) injections and tadalafil 5 mg oral tablets, tested alone and in combination
What this could lead to
If effective, this could offer men with erectile dysfunction a more efficient, possibly lower-cost treatment option, potentially reducing the need for daily medication.
What could go wrong
This is a mid-stage trial with a relatively small number of participants, so results may not apply to all men. PRP injections carry risks like pain or infection, and the combination may not prove better than either treatment alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

75 people

The number who actually took part.

Started

Jan 2024

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 70 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have a diagnosis of ED due to organic origin for at least 6 months prior to consent. * Sexually active in a stable, heterosexual relationship of more than three months duration. * Agree to attempt sexual intercourse at least 3 times per month for the duration of the study without being under the influence of alcohol or recreational drugs. * Agree to comply with all study related tests/procedures. * provide written informed consent. Exclusion Criteria: * Previous penile surgery of any kind (except circumcision ). * Previous history of penile fracture or priapism. * Psychogenic ED as determined by study investigator. * Anatomical (Peyronie's Disease or penile curvature that negatively influences sexual activity). * Patients using Intracavernosal Injection (ICI) for management of ED. * Patients with generalized polyneuropathy, or neurological conditions irrespective of cause, such as severe diabetes, multiple sclerosis or Parkinson's disease. * Have a serious comorbid illness/condition/behavior that, in the opinion of the investigator, may compromise the safety or compliance of the subject or preclude successful completion of the study. * Any history of significant psychiatric disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Erectile dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

erectile dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Erectile dysfunction

Contacts and locations

Locations

  • Ain Shams University Hospital

    Cairo, Abbasia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.